{Reference Type}: Journal Article
{Title}: Controlling the speed of antigens transport in dendritic cells improves humoral and cellular immunity for vaccine.
{Author}: Song Z;Jiao L;Wang D;Qiu Y;Miao J;Zhu T;Yu R;Wang Z;Zhou Y;Cai T;Zhang S;Liu H;Sun H;Sun Y;Liu Z;
{Journal}: Biomed Pharmacother
{Volume}: 177
{Issue}: 0
{Year}: 2024 Jun 27
{Factor}: 7.419
{DOI}: 10.1016/j.biopha.2024.117036
{Abstract}: Vaccines are an effective intervention for preventing infectious diseases. Currently many vaccine strategies are designed to improve vaccine efficacy by controlling antigen release, typically involving various approaches at the injection site. Yet, strategies for intracellular slow-release of antigens in vaccines are still unexplored. Our study showed that controlling the degradation of antigens in dendritic cells and slowing their transport from early endosomes to lysosomes markedly enhances both antigen-specific T-cell immune responses and germinal center B cell responses. This leads to the establishment of sustained humoral and cellular immunity in vivo imaging and flow cytometry indicated this method not only prolongs antigen retention at the injection site but also enhances antigen concentration in lymph nodes, surpassing traditional Aluminium (Alum) adjuvants. Additionally, we demonstrated that the slow antigen degradation induces stronger follicular helper T cell responses and increases proportions of long-lived plasma cells and memory B cells. Overall, these findings propose that controlling the speed of antigens transport in dendritic cells can significantly boost vaccine efficacy, offering an innovative avenue for developing highly immunogenic next-generation vaccines.